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Abstract Human b-amyloid (Ab) is believed to be
oneofthemaincomponentsofAlzheimer’sdisease,so
reduction of Ab is considered a key therapeutic target.
Using Agrobacterium-mediated nuclear transforma-
tion, we generated transgenic tomatoes for Ab with
tandem repeats. Integration of the human Ab gene into
the tomato genome and its transcription were detected
by PCR and Northern blot, respectively. Expression of
the Ab protein was conﬁrmed by western blot and
ELISA,andthen the transgenic tomatolineexpressing
the highest protein level was selected for vaccination.
Mice immunized orally with total soluble extracts
from the transgenic tomato plants elicited an immune
response after receiving a booster. The results indicate
that tomato plants may provide a useful system for the
production of human Ab antigen.
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Introduction
Alzheimer’s disease (AD) is a neurodegenerative
disease and the most common cause of dementia
which progresses over a prolonged period. According
to what is currently known about AD, it is believed to
be caused by the accumulation of beta-amyloid (Ab),
a toxic protein, in the brain. This ultimately results in
neuronal death (Taylor et al. 2002; Hardy and Salkoe
2002). Therefore, an effective strategy for the
prevention and treatment of the underlying causes
of AD would be to develop an agent that inhibits the
degeneration of the nervous system via the suppres-
sion of Ab generation, thus circumventing its
associated toxicity. Reducing the accumulation of
Ab may prevent or delay the onset of Alzheimer’s
disease. In a recent study, a variety of vaccination
advances were made using the Ab peptide. Schenk
et al. (1999) and Morgan et al. (2000) immunized
transgenic mice with puriﬁed Ab and raised an
antibody against the 42-amino acid form of Ab.
It is difﬁcult to produce Ab through E. coli or
yeast expression systems because of the toxicity of
the protein. For this reason, the possibility of Ab
expression in plant cells was investigated. Transgenic
plants are considered to be an alternative system for
the useful production of recombinant proteins, such
as antibodies, antigens, and therapeutics. During the
last 15 years, various antigens have been successfully
produced in plants and orally delivered to animals
resulting in induced immune responses (Mason et al.
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ﬁrst step was examining the effect of plant-derived
Ab on the induction of an immune response in
transgenic mice (Youm et al. 2005). Immunization
with potato-derived 5Ab42 can reduce the Ab burden
as well as many of the pathological features found in
a transgenic AD mouse model.
Various crops have been used to develop plant-
derived antigens. Each plant has advantages and
disadvantages (Sala et al. 2003). Plants such as
tobacco and alfalfa often produce proteins in their
green leaf tissues, but these tend to contain high
concentrations of phenolic and other potentially toxic
compounds. Seeds are likely to have fewer phenolic
compounds and a less complex mixture of proteins
and lipids than green leaves, which might be an
advantage during puriﬁcation. In the case of the
tomato plant, tomatoes can be eaten without heat
treatment, which may destroy the immunogenicity of
the antigen. Furthermore, transgenic tomatoes are
exhibiting considerable potential for the economic
production of proteins, with a few already being
marketed (Horn et al. 2004).
In the current study, we carried out the cloning and
expression of three to ﬁve tandem repeats forms of
Ab in tomato plants in an attempt to develop a plant-
derived AD vaccine. The ability of tomato-derived
Ab antigen to evoke antibody responses in mice was
analyzed. Immunized mice produced serum antibod-
ies against the Ab antigen. We conﬁrmed that it is
feasible to produce the Ab protein in transgenic
tomatoes and to serve as a novel delivery system for
the oral immunization of BALB/c mice.
Materials and methods
Plant material
Agrobacterium-mediatedtransformationofthetomato
was carried out with the Housechallenge cultivar as
described by Frary and Hamilton (2001). Seeds
were sterilized with 15% sodium hypochloride solu-
tion for 10 min and washed 2–3 times with sterile
distilled water. Sterilized seeds were cultivated on
MS tissue culture medium (Murashige and Skoog
1962)a t2 5 C with 16 h of light a day. Ten days later,
fully expanded cotyledons were used for the plant
transformation.
Tomato transformation and regeneration
Vector constructs were used as described in previous
work (Youm et al. 2005). Brieﬂy, the tandem-
repeated (3-mer to 5-mer, Fig. 1a) Ab cDNAs were
introduced into pMBP1, which yielded pMBPn
(3–5)Ab vectors (Fig. 1b). Cotyledons were cut in
two pieces and incubated with A. tumefaciens suspen-
sion and 75 mM acetosyringon for 20 min with
occasional gentle shaking. After drying off the excess
liquid from the bacterial suspension with sterile ﬁlter
paper,theexplantswereplacedupsidedownontoPetri
dishes containing MS medium supplemented with
30 mgsucrosel
-1,1 mgzeatinl
-1,and0.8 mgagarl
-1
Fig. 1 Construction of expression vectors and generation of
transgenic tomatoes. (a) Each multimer of Ab was visualized
in agarose gel stained with ethidium bromide. (b) Schematic
diagram of the plant expression vectors. The 3Ab,4 A b, and
5Ab genes were cloned under the control of the CaMV35S
promoter, which yielded pMBP3Ab, pMBP4Ab, and
pMBP5Ab, respectively. (c) In-vitro shoots regenerating from
cotyledon-disc callus (left). Transformants were selected on
MS medium containing 100 mg kanamycin l
-1 (middle).
Transgenic plants were then established in the greenhouse
(right)
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transferred on to MS agar medium containing 2 mg
zeatin l
-1, 100 mg kanamycin l
-1, and 1,000 mg
carbenicillin l
-1. The dishes were placed in a growth
chamber with a 16 h photoperiod at 25C, and the
medium was changed every 4 weeks. Regenerated
shoots were separated from calli forming on the
explants and cultured on MS medium with 50 mg
kanamycin l
-1 and 500 mg carbenicillin l
-1. The
transformants were transferred to the greenhouse to
grow as whole plants. Morphological characteristics,
such as shoot growth and fruit on the transgenic
plants, were compared with those of non-transgenic
plants. Hormones and antibiotics were purchased
from Duchefa co. (Haarlem, The Netherlands).
PCR analysis and Southern hybridization
The presence of inserted DNA in the tomato genome
was cross-checked by PCR analysis for both the
neomycin phophotransferase II (npt II) and Ab gene.
PCR analysis for the npt II gene was performed as
described previously(Kim et al. 2003). Total genomic
DNA from non-transformed (NT) plants was used as a
negative control and all putative kanamycin resistant
plants wereextractedasdescribed byDoyleandDoyle
(1987).A20 llPCRreactionmixcontained100 ngof
each primer, premix solution (Bioneer Co., Korea),
and 100 ng genomic DNA as template. Cycling
conditions were 94C for 45 min, 65C for 30 min,
and 72C for 30 min for a total 25 cycles. The primer
sequences used to amplify the Ab gene were 50-GGA
TCC ATG GAT GCA GAA TCC CGA CAT GAC-30
and 50-GGA TCC TCA CGC TAT GAC AAC ACC
GCC CAC-30. The ampliﬁed DNA fragments were
separatedbyelectrophoresisona1.5%agarosegeland
visualized by ethidium bromide staining.
Northern blot analysis
Total RNA from the leaves of NT plants and
transformed plants was isolated using the RNAgents
Total RNA isolation system (Promega, WI, USA)
according to the manufacturer’s instructions. Thirty
lg total RNA was denatured with formaldehyde and
formamide, fractionated in a 1% agarose gel using
MOPS buffer and then blotted to a positively charged
nylon membrane. The membranes were hybridized
with Dig-labeled Ab-speciﬁc probe at 68C overnight
and detected using the Dig Detection kit (Roche Co.,
Germany).
Western and ELISA analysis to detect Ab protein
Protein extraction and analysis of 3Ab-expressing
lines were performed as described in previous studies
(Kim et al. 2003; Youm et al. 2005). Total soluble
protein (TSP) was extracted from NT control and
transgenic tomato plants by homogenizing in extrac-
tion buffer, and quantiﬁed by the Bradford method.
Western blot analysis was performed using anti-
Ab monoclonal antibody, 4G8 (1:5,000 dilution,
Signet Lab., MA, USA). A chemiluminiscence kit
(Amersham Bioscience, UK) was used to visualize
the speciﬁc bands. The recombinant 3Ab protein
levels were determined via direct ELISA assays. The
ELISA plate were coated with 100 lg TSP in 0.05 M
carbonate/bicarbonate (pH 9.6) buffer and incubated
with anti-Ab monoclonal antibody (6E10, 1:1,000
dilution, Signet Lab.). The amount of Ab proteins in
TSP was estimated with Ab42 peptide as a standard.
Vaccination of Balb/c mice with transformed
plant extract
A group of 15 month old Balb/c mice was used in the
immunization experiments. Ten mice from each
group were fed extracts from transgenic tomato line
pMBP3Ab-6 or NT control plants plus 10 lg Cholera
Toxin B subunit (CTB) (Sigma) once a week for
3 weeks. Prior to the oral immunizations, 0.2 ml
sodium bicarbonate was applied by gastric gavage to
each of the mice, in order to neutralize stomach
acidity. Blood samples were collected just before the
examination (day 0) and after primary immunization.
Each mouse was given a booster at 4 weeks after the
3rd feeding with 15 lg of synthetic Ab peptide
emulsiﬁed in alum. Sera were collected from the mice
2 weeks after boosting, and all blood samples were
analyzed by ELISA assays.
Direct ELISA for anti-Ab antibody production
Flat-bottom ELISA plates were coated overnight at
4C with Ab 42 (0.1 lg/well of 0.05 M carbonate/
bicarbonate buffer, pH 9.6) to measure the titers of
anti-Ab antibodies in the sera of immunized mice.
Most of the procedures were the same as previously
Biotechnol Lett (2008) 30:1839–1845 1841
123described (Youm et al. 2005). Brieﬂy, the coated
plates were incubated with serum samples, diluted
1:100 in blocking buffer, for 2 h at room temperature.
The plates were then incubated with mouse IgG-
conjugated horseradish peroxidase (secondary anti-
body), diluted 1:1,000 in blocking buffer, for 2 h at
room temperature. To stop the reaction, 100 ll
tetramethylbenzidine substrate (Pierce, IL, USA)
and H2O2 were added. After incubation, the reaction
was measured at 450 nm with an ELISA reader.
Results
Generation of transgenic tomato plants
Three multimer forms of Ab, trimer to pentamer, were
successfully introduced into the pMBP1 vector. The
immunogenicity of each multimer form of synthetic
Ab was determined by western blot with an anti-Ab
antibody. Four weeks after co-cultivation, shoots were
developedfromcotyledon-discsegments(Fig. 1c,left)
and putative transformants selected through kanamy-
cin resistance (Fig. 1c, middle). We obtained more
than 20 individual plantlets and carried out further
analysis of Ab expression on selected transgenic
plants. Non-transformed tomato plants regenerated
from non-contaminated cotyledon discs were used as
negative controls. The selected transformants exhib-
ited similar growth with no phenotypic abnormalities
compared to the NT plants (Fig. 1c, right).
Analysis of Ab expression in tomato
transformants
The presence of npt II in the genomic DNA isolated
from transformants and NT tomato plants was
detected by PCR ampliﬁcation (data not shown).
The expected Ab-speciﬁc bands of approximately
450, 600, and 750 bp were seen in the transformants,
respectively (Fig. 2a). No DNA product was detected
in NT plant. Selecting the transformants by PCR
analysis, we determined the insertion of three to ﬁve
repeated Ab genes into the genomic DNA of these
tomato plants.
The transcription of 3Ab,4 A b, and 5Ab DNA in
transgenic plants was determined by Northern anal-
ysis. Fig. 2b shows the results of an experiment where
selected transformants harboring the pMBPn(3–5)Ab
constructs and a NT control were probed. An Ab-
speciﬁc RNA was found in six lines of transgenic
3Ab, two lines of transgenic 4Ab, and one line of
transgenic 5Ab, but at quite different levels.
Based on Northern analysis, only transgenic 3Ab
lines were further analyzed for recombinant protein
expression by western blotting and ELISA analysis
using a monoclonal speciﬁc antibody. The TSPs were
extracted from leaves of the individual transgenic
tomato lines 3Ab-6 and -9. Transgenic potato line
pMBP5Ab-1 (Youm et al. 2005) was used as positive
control to detect Ab-speciﬁc protein in the transgenic
tomatoes. We conﬁrmed the highest level of 3
tandemerized Ab protein in transgenic line 3Ab-6
(Fig. 3a). Using direct ELISA analysis, we quantiﬁed
the level of 3Ab protein expression in the transgenic
plants expressing pMBP3Ab vectors (Fig. 3b). The
expression of recombinant Ab protein in lines 3Ab-6
and -9 were 80 and 58 ng/ml in the applied extract,
respectively.
Immunogenicity of tomato-derived 3Ab
In our previous report (Youm et al. 2005), mice
immunizedwithpotato-derived5Abdevelopedprimary
Fig. 2 PCR and Northern blot analysis of the Ab transgenic
lines (a) PCR analysis for the presence of Ab gene in
transgenic tomato plants. Plant DNA was isolated from leaf
extracts and PCR was performed with a pair of primers which
speciﬁcally amplify a 3Ab,4 A b, and 5Ab fragments. M1, 1 kb
marker; M2, 100bp marker; NT, non-transformed plant as
negative control; each numbers represent independent trans-
genic lines carrying expression cassette for 3Ab,4 A b,o r5 A b.
Arrows indicate 500bp. (b) Detection of Ab mRNA in
transgenic plants. Twenty ﬁve lg of total RNA from NT and
selected independent lines by PCR analysis were loaded on
1.0% formaldehyde agarose gel and hybridized by an Ab-
speciﬁc Dig-labeled probe
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Ab burden of the brain. In the present study, we
attemptedtodeterminewhetherthe3Abgeneratedina
transgenic tomato was able to induce an immune
response in Balb/c mice. In groups of ten, Balb/c mice
were immunized with extracts from transgenic line
3Ab-6 or NT plants. The protein was extracted from
5 g tomato plants and freeze-dried yielding a total of
0.2 ml concentrate. Mice were treated three times at
weekly intervals and boosted 7 weeks after the initial
feedingwith15 lgofsyntheticAb42peptideemulsiﬁed
in alum. In order to determine the anti-Ab response,
we collected sera on day 0, before antigen inoculation,
as a control; after the third feeding; and after the
booster. The sera of the mice immunized with NT
plant extract exhibited no induction of cross-reactive
antibodies (Fig. 4). On the hand, mice fed the extract
from transgenic tomato line 3Ab-6 exhibited a
signiﬁcant increase in serum reactivity against Ab
after boosting, particularly in the levels of serum 3Ab-
speciﬁc antibodies.
Discussion
The expression levels were different between the
various transform ants and can be different between
organs of the same plant, which depends on the site
the foreign DNA is inserted into the plant genome.
Ma et al. (2003) reported that the expression of HEV
in tomato fruits (61 ng/g fresh weight) is higher than
in leaves, and is similar to that of Bag in transgenic
tomatoes (Lou et al. 2007). The higher expression of
target protein in edible tissue may be helpful for
producing an oral vaccine. In this study, a high level
of Ab transcript was found in the transgenic 3Ab
lines, with a lower expression of the transgenic 4Ab
and 5Ab lines than expected. It is not caused by the
multimer form of Ab, because we previously showed
Fig. 3 Analysis of tomato-derived 3Ab protein. (a) Western
blot analysis of transgenic tomato lines. An equal amount of
total soluble protein (TSP) from two transgenic plant lines
3Ab-6 and -9 were loaded and the 3Ab protein was detected by
anti-Ab monoclonal antibody, 4G8. Transgenic potato line
M5Ab-1 was used as positive control (PC) to detect Ab-
speciﬁc protein in transgenic tomato. (b) Quantitative analysis
of expressed 3Ab in transgenic tomato plants using direct
ELISA with each transgenic plant TSP and anti-Ab monoclo-
nal antibody, 6E10. The amount of 3Ab proteins in TSP was
calculated using Ab42 peptide as a standard. Each bar
represents an average of three samples ± standard error
Fig. 4 Immunization of Balb/c mice with tomato-derived 3Ab
resulted in anti-Ab antibody responses subsequent to the oral
uptake of transgenic plant materials. Mice were gavaged by
extracts from either non-transfromed (NT) plants (slash line
bar) or transgenic line 3Ab-6 (black bar) with CTB adjuvant.
Bleeding time constitutes just before the examination (1st);
after primary immunization, which was three times with
weekly intervals (2nd); and after a booster at 7 weeks (3rd).
Each bar represents an average of immunized mice ± standard
error
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et al. 2005).
An advantage of using tomatoes as an oral vaccine
vector is that the tomato is a freshly eaten fruit,
meaning it is possible to acquire immunity at the same
time as enjoying food. However, the accumulation of
protein in the tomato itself is low as it contains only
0.7% protein in the fresh fruit and the expression
levels of foreign protein are much lower. In the
context of this study, tomato-derived3Abis expressed
at lower levels than potato-derived 5Ab using the
same vector system. This will make it difﬁcult when
administering the plant-derived vaccine. To resolve
this problem, the use of stronger promoters, plant-
derived leader sequences and signal peptides, plant-
optimized synthetic genes, and targeting the protein
for retention in the appropriate tissue (Stoical et al.
2003; Tackaberry et al. 2003; Lauterslager et al.
2001) have been investigated. In our previous study,
5Ab protein was increased up to 0.1% of TSP by
introducing a strong promoter, signal peptide, and
retention signal into the expression vector (Youm
et al. 2005). All of these studies provided successful
experiences in improving the expression level of
antigen in transgenic tomatoes. In the present study,
we introduced cDNA encoding 3Ab into the pMBP1
expression vector driven by the CaMV 35S promoter
without any enhancing factor, though there were
many reconstruction possibilities to achieve high
expression. We are currently engaged in research for
increasing the expression level of foreign proteins
using a tissue-speciﬁc promoter or signal peptide for
subcellular localization.
In several reports, an immediate and strong
secondary antibody response was observed in animals
receiving a boost of commercial vaccine (Richter
et al. 2000; Kong et al. 2001). Memory immune cells
had apparently been established as a result of oral
immunization. Our results in this study showed that
mice fed extract from transgenic tomato line 3Ab-6
exhibited a signiﬁcant increase in serum against Ab
after boosting compared to the primary antibody
response. Although we did not reveal a reduction of
existing plaques in the brain of mice challenged with
tomato-derived 3Ab, we expect a similar result to
what was found in our previous study (Youm et al.
2005) induced serum antibodies affect amyloid
plaques in the brain resulting in a reduction in
amyloid number or amyloid burden in the brain
(Schenk et al. 1999; Morgan et al. 2000; Youm et al.
2005).
One promising approach to the prevention and
treatmentofADisbased uponstimulatingtheimmune
system to reduce Ab in the brain. There is still much
optimism in regard to the eventual development of a
vaccine strategy using Ab (Gelinas et al. 2004). This
study constitutes another example of active immuni-
zation, and also represents a unique approach in which
transgenic plants expressing Ab protein are used to
produce the vaccine.
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